Brilique



Indications and Reactions:

Role Indications Reactions
Primary
Acute Coronary Syndrome 27.0%
Acute Myocardial Infarction 20.4%
Coronary Artery Disease 8.3%
Hypertension 7.9%
Myocardial Infarction 7.2%
Stent Placement 5.1%
Thrombosis Prophylaxis 4.4%
Hypercholesterolaemia 2.7%
Atrial Fibrillation 2.1%
Percutaneous Coronary Intervention 2.0%
Diabetes Mellitus 1.7%
Myocardial Ischaemia 1.6%
Angina Unstable 1.4%
Infarction 1.4%
Antiplatelet Therapy 1.3%
Cardiac Disorder 1.3%
Angina Pectoris 1.0%
Anticoagulant Therapy 1.0%
Gastritis Prophylaxis 1.0%
Ischaemic Heart Disease Prophylaxis 1.0%
Thrombosis In Device 20.6%
Thrombocytopenia 10.1%
Dyspnoea 7.9%
Death 6.9%
Cerebral Haemorrhage 5.8%
Haemorrhage 5.3%
Drug Ineffective 3.7%
Melaena 3.7%
Subdural Haematoma 3.7%
Atrioventricular Block Complete 3.2%
Bradycardia 3.2%
Myocardial Infarction 3.2%
Post Procedural Haemorrhage 3.2%
Rhabdomyolysis 3.2%
Thrombosis 3.2%
Atrioventricular Block 2.6%
Malaise 2.6%
Pain In Extremity 2.6%
Renal Failure 2.6%
Sinus Arrest 2.6%
Secondary
Product Used For Unknown Indication 20.6%
Acute Myocardial Infarction 20.4%
Acute Coronary Syndrome 12.6%
Coronary Artery Disease 10.3%
Myocardial Infarction 9.0%
Stent Placement 5.1%
Hypertension 3.1%
Thrombosis Prophylaxis 2.9%
Coronary Artery Bypass 2.2%
Coronary Arterial Stent Insertion 2.1%
Blood Cholesterol Increased 1.5%
Cardiac Disorder 1.5%
Pneumonia 1.5%
Dementia Alzheimer's Type 1.3%
Atrial Fibrillation 1.2%
Angina Unstable 1.0%
Intracardiac Thrombus 1.0%
Percutaneous Coronary Intervention 1.0%
Diabetes Mellitus 0.9%
Cardiac Failure 0.7%
Thrombosis In Device 14.3%
Transaminases Increased 11.6%
Panic Attack 8.9%
Subdural Haematoma 7.1%
Thrombocytopenia 6.3%
Unresponsive To Stimuli 6.3%
Dyspnoea 5.4%
Haemorrhage 5.4%
Rhabdomyolysis 4.5%
Haematoma 3.6%
Haemorrhagic Stroke 3.6%
Bradycardia 2.7%
Cerebral Haemorrhage 2.7%
Hepatic Necrosis 2.7%
Impaired Driving Ability 2.7%
Ischaemic Stroke 2.7%
Pain In Extremity 2.7%
Type 2 Diabetes Mellitus 2.7%
Vomiting 2.7%
Angioedema 1.8%
Concomitant
Product Used For Unknown Indication 19.1%
Hypertension 9.6%
Prophylaxis 7.8%
Cardiovascular Event Prophylaxis 6.1%
Diabetes Mellitus 5.2%
Myocardial Infarction 5.2%
Rheumatoid Arthritis 5.2%
Acute Myocardial Infarction 4.3%
Osteoporosis 4.3%
Type 2 Diabetes Mellitus 4.3%
Abdominal Pain Upper 3.5%
Acute Coronary Syndrome 3.5%
Infarction 3.5%
Pain 3.5%
Angioplasty 2.6%
Cardiac Disorder 2.6%
Coronary Artery Disease 2.6%
Coronary Revascularisation 2.6%
Endocarditis 2.6%
Cardiac Failure 1.7%
Myocardial Infarction 10.7%
Rhabdomyolysis 10.7%
Dyspnoea 7.1%
Long Qt Syndrome 7.1%
Thrombocytopenia 7.1%
Ventricular Fibrillation 7.1%
Acute Coronary Syndrome 3.6%
Bradycardia 3.6%
Cardiac Arrest 3.6%
Cardiac Operation 3.6%
Drug Ineffective 3.6%
Drug Interaction 3.6%
Dyspnoea At Rest 3.6%
Encephalopathy 3.6%
Gamma-glutamyltransferase 3.6%
Gamma-glutamyltransferase Increased 3.6%
Heart Rate Irregular 3.6%
Hypoglycaemia 3.6%
Hypokalaemia 3.6%
Incorrect Route Of Drug Administration 3.6%
Interacting
Product Used For Unknown Indication 28.1%
Coronary Artery Disease 12.3%
Thrombosis Prophylaxis 10.5%
Acute Coronary Syndrome 7.0%
Hypertension 7.0%
Oedema 5.3%
Anticoagulant Therapy 3.5%
Chest Pain 3.5%
Hypercholesterolaemia 3.5%
Pain 3.5%
Stent Placement 3.5%
Type 2 Diabetes Mellitus 3.5%
Depression 1.8%
Hypertension Arterial 1.8%
Percutaneous Coronary Intervention 1.8%
Prophylaxis 1.8%
Stemi 1.8%
Drug Interaction 20.0%
Rhabdomyolysis 20.0%
Lung Neoplasm Malignant 10.0%
Melaena 10.0%
Myalgia 10.0%
Oedema 10.0%
Puncture Site Haemorrhage 10.0%
Urine Abnormality 10.0%